In Practise Logo
In Practise Logo - Blue
In Practise Logo
IP Interview
Published April 2, 2024

Danaher: Cytiva, HyClone, & Cell Culture Sales

Executive Bio

Former Sales Specialist at Cytiva

Interview Transcript

Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.

This is a snippet of the transcript.to get full access.

Why haven't larger companies like Merck, Millipore attempted to enter this market? If the technology hasn't changed for 20 years and companies like GE have a huge market share, why hasn't a competitor tried to enter this space?

They have attempted, perhaps without success. There were many patented aspects when it comes to chromatography resins. Millipore Sigma does have some resins similar to Thermo Fisher. They can compete to some extent, but Thermo Fisher has products that Cytiva cannot compete with, despite their offerings. The credibility within the customer base also plays a significant role.

This is a snippet of the transcript.to get full access.

Free Sample of 50+ Interviews

Sign up to test our content quality with a free sample of 50+ interviews.

Or contact sales for full access

© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.